Neurophysiology devices market seen rising to $2.51 billion by 2030

The neurophysiology devices and equipment market is projected to grow from $1.76 billion in 2026 to $2.51 billion by 2030, driven by rising neurological disease rates, more point-of-care diagnostics and wider use of portable and wireless systems. North America remained the largest regional market in 2025, while new government funding and clinical demand are shaping the next phase of growth.

Why it matters: - Neurophysiology devices help diagnose and monitor disorders of the nervous system, including spinal cord dysfunction, peripheral nerve damage and brain abnormalities. - Rising neurological disease burden is increasing demand for diagnostic and monitoring tools used in clinical care and research. - The market's expected jump to $2.51 billion by 2030 signals stronger commercial momentum for device makers and healthcare providers.

What happened: - The Business Research Company said the neurophysiology devices and equipment market rose from $1.72 billion in 2025 to $1.76 billion in 2026, a 2.3% CAGR. - The company projected the market will reach $2.51 billion by 2030, reflecting a 9.3% CAGR over the forecast period. - North America was the largest regional market in 2025, and Western Europe was the second-largest. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also added market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies analysis and future trend analysis in its 2026 reports. - Download a free sample of the report. - View the full report.

The details: - Neurophysiology devices and equipment assess functions of the nervous system. - These tools are used to evaluate dysfunctions in the spinal cord and peripheral nerves. - The devices also detect brain abnormalities and monitor nerve damage. - The market's historical growth was driven by advances in neurological testing technologies such as EMG and EEG. - Other drivers included more surgical procedures, expansion of hospital neurology departments and higher clinical research activity. - Looking ahead, growth is expected to come from point-of-care diagnostic tools, higher rates of nerve disorders, technological miniaturization, ambulatory care centers and expanded education and training programs. - Emerging trends include more portable devices, broader intraoperative monitoring, growing use of wireless recording systems, expansion of neurodiagnostic laboratories and a stronger focus on early detection of neurological conditions. - Neurological disorders include more than 600 conditions, including brain tumors, epilepsy, Parkinson's disease and Alzheimer's disease. - Neurological diseases are a leading cause of Disability Adjusted Life Years, a measure of years lost to ill health, disability or premature death. - Cancer Research UK said in February 2023 that annual new UK cases of brain, central nervous system and intracranial tumors are expected to rise from about 12,600 in 2023-2025 to about 13,600 in 2038-2040. - The National Institutes of Health issued a funding opportunity announcement in 2023 encouraging first-in-human and early-stage clinical studies for next-generation invasive devices. - The NIH initiative is aimed at accelerating development and adoption of new neurophysiology technologies.

Between the lines: - The market outlook suggests a shift from incremental growth to faster expansion as portable, wireless and point-of-care systems gain traction. - Government funding and rising disease prevalence are reinforcing each other, creating a stronger case for investment in next-generation diagnostics. - The report's added analytics tools point to more demand from investors and companies seeking sharper market visibility and forecasting.

What's next: - Demand is likely to build as more patients are diagnosed with neurological conditions and more care moves into ambulatory settings. - Product development will likely focus on smaller, more portable and more connected neurophysiology systems. - Clinical adoption may increase for intraoperative monitoring and early-detection workflows as laboratories and training programs expand. - Contact details for the report include Saumya Sahay at marketing@tbrc.info and The Business Research Company at www.thebusinessresearchcompany.com. - The company listed social channels on LinkedIn, Facebook and X.